A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16).

  • Kim, Se Hyun; 
  • Suh, Koung Jin; 
  • Im, Seock-Ah; 
  • Lee, Kyung-Hun; 
  • Kim, Min Hwan; 
  • ... Kim, Hee Jun; 
  • 외 11명
Citations

WEB OF SCIENCE

1
제목
A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16).
저자
Kim, Se Hyun; Suh, Koung Jin; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Min Hwan; Sohn, Joohyuk; Park, Yeon Hee; Kim, Ji-Yeon; Jeong, Jae Ho; Lee, Kyoung Eun; Choi, In Sil; Park, Kyong Hwa; Kim, Hee Jun; Cho, Eun Kyung; Park, So Yeon; Kim, Milim; Kim, Jee Hyun
DOI
10.1200/JCO.2022.40.16_suppl.1098
발행일
2022-06
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
40
호
16S